awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q35783451-200C5A91-BCAC-4B87-82D4-04ADF794029C
Q35783451-200C5A91-BCAC-4B87-82D4-04ADF794029C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35783451-200C5A91-BCAC-4B87-82D4-04ADF794029C
Pharmacologic inhibition of mTOR improves lapatinib sensitivity in HER2-overexpressing breast cancer cells with primary trastuzumab resistance.
P2860
Q35783451-200C5A91-BCAC-4B87-82D4-04ADF794029C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35783451-200C5A91-BCAC-4B87-82D4-04ADF794029C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
736f85f9ffb29f473613a410d45ba61c34b31338
P2860
Lapatinib monotherapy in patients with relapsed, advanced, or metastatic breast cancer: efficacy, safety, and biomarker results from Japanese patients phase II studies.